Search

ATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Soc

LOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a pr

LOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, accor

LOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having

Other headlines: – Tapering, TNF-inhibitor drugs is possible in people with rheumatoid arthritis in remission. – TNF-inhibitors reduce the need for hospitalisation and surgery. – Pat

LOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the

LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are

LOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Hear

Other headlines: – New monoclonal antibody reduces LDL-cholesterol in statin-intolerant patients. – Aspirin effective for extended treatment of venous thromboembolism. – Breast cance

BANGKOK—60 million lives could be saved — most of them in low- and middle-income countries — by taking effective measures to combat any future pandemic of influenza.

BANGKOK AND PHNOM PENH—Protecting the planet from infections such as influenza is the mission of a dedicated team of scientists working for the London School of Hygiene & Tropical Medicine workin

PHNOM PENH, CAMBODIA—Scientists from the London School of Hygiene & Tropical Medicine are working along the Thai-Cambodian border: the ‘epicentre’ of resistance to artemisinin combina